Paul Nghiem, MD, PhD, FAAD
SESSIONS
S028 Late-breaking Research: Session 1
Mar 8, 2025
•
9:00 AM - 12:00 PM
•
Chapin Theater - Level III
S040 Late-Breaking Research: Session 2
Mar 8, 2025
•
1:00 PM - 4:00 PM
•
Chapin Theater - Level III
DISCLOSURES
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);